ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Going Indian

Going 'Indian' Hansavivek GLAXO LABORATORIES (INDIA) has identified, as part of its diversification studies, several organic chemicals used in the drugs industry and other industries. It has applied for an industrial licence to manufacture these chemicals at a new factory proposed to be set up in a bakward area. The company is also examining other opportunities for diversification through new projects on its own or by joint ventures. It has received a letter of intent from government for manufacture of rive drugs, viz, iliuprofen, sotalol hydrochloride, levamisole, norethisterone and pentazocine hydrochloride/lactate, at a new factory to be established at Anklesh- war in Gujarat. Construction work on the project is expected to commence by the end of the year. The company has submitted its application as far back as in May 1980. The delay in the grant of the letter of intent will mean a substantial increase in the project cost. The Company has got letters of intent for substantial expansion in production of betamethasone and for manufacture of additional betamethasone formulations. The conversion of these two letters of intent into industrial licences is expected shortly. The writ petition filed, in the Delhi High Court, regarding the betamethasone price fixation, is still pending. The Court has directed the parties to try and resolve the matter amicably. The government has turned down the company's request to convert the letter of intent for salbu- tamol into an industrial licence.

Dear reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top